The Globe and Mail notes the continuing debate in the Canadian parliament over stem cell research legislation. As in the US, uncertainty over the legal future of research is damaging progress. Funding for stem cell based regenerative medicine is much lower than it might otherwise be in both public and private sectors. Longer delays from current and threatened legislation mean more death and suffering before working stem cell therapies can be widely commercialized. I encourage you to raise your voices in support of medical research; ask your elected representatives why they are blocking vital, promising research.